Literature DB >> 24720604

Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study.

P Kant1, R R Bhowate, N Sharda.   

Abstract

OBJECTIVES: Oral submucous fibrosis (OSMF) is an insidious chronic disease that is associated with significant functional morbidity and an increased risk for malignancy. It initially affects the lamina propria of the oral mucosa, and, as the disease progresses, it involves the submucosa and deeper tissue, including muscles of the oral cavity, resulting in loss of fibroelasticity. OSMF is a pre-malignant condition mainly caused by areca nut chewing. The aim of this study was to find out the involvement of muscles of mastication and facial expression in patients with OSMF by assessing the cross-sectional thickness and activity of the masseter, anterior temporalis and orbicularis oris muscles by ultrasonography and electromyography and comparing with healthy controls and also to find out any correlation between the ultrasonographic cross-sectional thicknesses of the masseter, anterior temporalis and orbicularis oris muscles with electromyographic activity.
METHODS: 40 patients with OSMF were included in the study group, and the patients were divided into four groups on the basis of interincisal mouth opening, i.e. Group I (mouth opening >35 mm), Group II (mouth opening between 30 and 35 mm), Group III (mouth opening between 20 and 30 mm) and Group IV (mouth opening <20 mm). Ultrasonographic cross-sectional thickness and electromyographic activity (amplitude and duration) of the masseter, anterior temporalis and orbicualris oris muscles were recorded in patients with OSMF and 20 controls. Intergroup comparison of ultrasonographic cross-sectional thickness and activity (amplitude and duration) was done, and Pearson's correlation coefficient was applied to find out any relation between ultrasonographic and electromyographic findings.
RESULTS: Thickness and activity of the masseter muscle was significantly reduced in Group IV (mouth opening <20 mm) when compared with the control group. The anterior temporalis and orbicularis oris muscles remained unaffected. A positive correlation was observed between the thicknesses of the masseter muscle and the amplitude in Groups I, II and III; the anterior temporalis muscle in Group II and the control group; and the orbicularis oris muscle in Groups II, III and IV.
CONCLUSIONS: It was concluded that, among the muscles studied, there was an early involvement of the masseter muscle in patients with OSMF compared with that of other muscles.

Entities:  

Keywords:  OSMF; electromyography; ultrasonography

Mesh:

Year:  2014        PMID: 24720604      PMCID: PMC4064626          DOI: 10.1259/dmfr.20130016

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  17 in total

1.  Ultrasonographic assessment of local cross-sectional dimensions of masseter muscle sites: a reproducible technique?

Authors:  R Emshoff; S Bertram; I Brandlmaier; G Scheiderbauer; A Rudisch; G Bodner
Journal:  J Oral Rehabil       Date:  2002-11       Impact factor: 3.837

2.  Cross-sectional characteristics of the masseter muscle: an ultrasonographic study.

Authors:  S Bertram; I Brandlmaier; A Rudisch; G Bodner; R Emshoff
Journal:  Int J Oral Maxillofac Surg       Date:  2003-02       Impact factor: 2.789

3.  Clinical use of qualitative electromyography in the evaluation of jaw muscle function: a practitioner's guide.

Authors:  Sven E Widmalm; You-Sik Lee; Duane C McKay
Journal:  Cranio       Date:  2007-01       Impact factor: 2.020

Review 4.  Oral submucosal fibrosis--a preventable disease.

Authors:  V Jayanthi; C S Probert; K S Sher; J F Mayberry
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

5.  Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases.

Authors:  J N Khanna; N N Andrade
Journal:  Int J Oral Maxillofac Surg       Date:  1995-12       Impact factor: 2.789

6.  Selective glycogen depletion in skeletal muscle fibres of man following sustained contractions.

Authors:  P D Gollnick; J Karlsson; K Piehl; B Saltin
Journal:  J Physiol       Date:  1974-08       Impact factor: 5.182

7.  A new ultrastructural finding in oral submucous fibrosis.

Authors:  W H Binnie; R A Cawson
Journal:  Br J Dermatol       Date:  1972-03       Impact factor: 9.302

8.  Oral submucous fibrosis.

Authors:  J J Pindborg; S M Sirsat
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1966-12

9.  Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase.

Authors:  R Kuttan; P V Donnelly; N Di Ferrante
Journal:  Experientia       Date:  1981-03-15

10.  Ultrasound image of human masseter muscle related to bite force, electromyography, facial morphology, and occlusal factors.

Authors:  M Bakke; A Tuxen; P Vilmann; B R Jensen; A Vilmann; M Toft
Journal:  Scand J Dent Res       Date:  1992-06
View more
  4 in total

1.  Proprioceptive ability at the lips and jaw measured using the same psychophysical discrimination task.

Authors:  Ellie Frayne; Susan Coulson; Roger Adams; Glen Croxson; Gordon Waddington
Journal:  Exp Brain Res       Date:  2016-02-09       Impact factor: 1.972

Review 2.  Magnetic resonance and sonographic imagings of masticatory muscle myalgia in temporomandibular disorder patients.

Authors:  Yoshiko Ariji; Eiichiro Ariji
Journal:  Jpn Dent Sci Rev       Date:  2016-09-06

3.  Muscle Activity in Pre-Treatment and Post-Treatment Oral Submucous Fibrosis Patients: Electromyography Study.

Authors:  Santosh R Patil; G Maragathavalli; D N S V Ramesh; Mohammad Khursheed Alam
Journal:  Int J Clin Pract       Date:  2022-09-30       Impact factor: 3.149

4.  Association of masseter muscles thickness and facial morphology with facial expressions in children.

Authors:  Christophe Guédat; Ourania Stergiopulos; Stavros Kiliaridis; Gregory S Antonarakis
Journal:  Clin Exp Dent Res       Date:  2021-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.